Dr. Estil August Vance III, MD

  • Dallas, TX
  • Hematologist and oncologist
NPI1477596344PAC ID5294746020
Medicare services, 2024
5,439
Medicare patients, 2024
349
Part D claims, 2024
691
Publications
7
Clinical trials
1
Practice address
7777 Forest Lane, Dallas, TX 75230
Practice phone
Call (972) 566-6222
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Medical City Dallas Hospital

Hospital · Dallas, Texas

See all 3 affiliations

Find Dr. Vance's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Estil August Vance III is a hematologist and oncologist in Dallas, Texas

Dr. Vance practices at Medical City Dallas Hospital in Dallas, Texas, part of HCA Healthcare.

Dr. Vance's NPI, 1477596344, was assigned on June 14, 2006. Dr. Vance graduated from The Johns Hopkins University School of Medicine in 1990. Dr. Vance's Texas license number on file is K6385.

NPI and contact details
Medicare PAC ID
5294746020
NPI enumeration date
June 14, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(972) 566-6222
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
62
Medical school graduation
1990

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Estil August Vance III practices at Medical City Dallas Hospital in Dallas, Texas

Dr. Vance's primary practice is Medical City Dallas Hospital, at 7777 Forest Lane, Dallas, TX 75230 in Dallas County. The practice phone is (972) 566-6222.

Source: Dmand AI Affiliation Data

Dr. Estil August Vance III is affiliated with 2 sites of care and 1 medical group

Dr. Vance's primary practice is Medical City Dallas Hospital in Dallas, Texas, part of HCA Healthcare. The medical group on file is Texas Oncology. Dmand AI also links Dr. Vance to 1 more hospital, named with a free account.

See all 3 affiliations for Dr. Vance

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Estil August Vance III's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vance practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Medical City Dallas HospitalAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Vance practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across HCA Healthcare and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Estil August Vance III is one of 814 hematologists and oncologists in Texas

Hematology and oncology is Dr. Vance's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Vance is board certified in medical oncology by the National Board of Physicians and Surgeons. Dr. Vance has a license on file in Texas.

Specialties and state licenses

  • Hematology and oncology, TexasPrimaryLicense K6385 · 1998 to 2025 · taxonomy 207RH0003X

Clinical focus

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, lymphoma and multiple myeloma among the conditions Dr. Vance treats.

Hematologists and oncologists near Dr. Vance

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Estil August Vance III billed Medicare for 5,439 services in 2024

CMS data shows 5,439 Medicare services from Dr. Vance across 32 procedure codes in 2024, for 349 Medicare patients. Medicare paid $175,207 for them.

Medicare services, 20245,439
Medicare patients349
Paid by Medicare$175,207
Procedure codes32

Dr. Vance's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 2,5722024: 2,22014%
Lab and pathology
2023: 1,6272024: 2,13031%
Surgery
2023: 2332024: 40172%
Tests and treatments
2023: 3132024: 34410%
Drugs given in the office
2023: 5232024: 31240%
Other services
2023: 02024: 17
Imaging
2023: 122024: 1525%

Where Dr. Vance's Medicare services took place, 2024

  • In an office3,54365%
  • In a facility1,89635%

Dr. Vance compared with the Texas median for hematologists and oncologists, 2024

  • Dr. Vance
  • Texas median
Medicare services
5,439vs 1,1624.7 times
Medicare patients
349vs 25139% above
Part D claims
426vs 48913% below

Medians across 758 hematologists and oncologists in Texas with Dmand AI profiles that report each measure.

Dr. Vance's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Vance

Need commercial claims for Dr. Vance?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Vance and other hematologists and oncologists in Texas.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Estil August Vance III treated 349 Medicare patients in 2024, average age 71

CMS counts 349 Medicare patients who saw Dr. Vance in 2024. The largest group is 65 to 74, with 198 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vance's median patient age at 65, with 45% women.

Medicare patients, 2024349
Average age71
Average risk score2.62
Also on Medicaid6%

Dr. Vance's Medicare patients by age, 2024

Dr. Vance's Medicare patients by sex, 2024

  • Women14241%
  • Men20759%

Chronic conditions among Dr. Vance's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol69%
  3. Arthritis44%
  4. Diabetes39%
  5. Chronic kidney disease34%
  6. Ischemic heart disease33%
  7. Mood disorders28%
  8. Anxiety27%

Share of Medicare patients with each condition. A patient can have several.

Dr. Vance's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 65

Patient panel by sex, all payers

  • Women45%
  • Men55%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Estil August Vance III wrote 691 Medicare Part D claims in 2024

In 2024, Dr. Vance wrote 691 Medicare Part D claims for 116 patients. 89% of them were for generic drugs. CMS names the drug for 426 of them, across 18 drugs with 11 or more claims each, at $490,920 in total drug cost. In 2023, CMS named 504 claims across 19 drugs.

Part D claims, 2024691
Drugs named by CMS18
Total drug cost$490,920
Part D patients116

Dr. Vance's Part D claims by kind of drug, 2024

  • Generic617 claims89%
  • Brand-name74 claims11%

Dr. Vance's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Vance's Part D claims, 2024

  • Opioids2%13 of 691 claims
  • Antibiotics5%36 of 691 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 5042024: 42615%

Drugs named by CMS: 18 in 2024, 19 in 2023.

See all prescribing by Dr. Vance

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Estil August Vance III scored 85 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Vance for performance year 2024, reported through an alternative payment model (APM). Dr. Vance accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vance as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Vance's MIPS scores, performance year 2024

  • 85of 100Final score
  • 67.5of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Vance by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Estil August Vance III has 7 publications on record

Dmand AI links 7 papers to Dr. Vance in 2025. Dr. Vance has published most often in Clin Infect Dis. Dr. Vance's most frequent co-authors are Vikas Bhushan, MD, Tara Brooke Kelley Gregory, MD and Charles F. Lemaistre, MD.

Papers7

Dr. Vance's most frequent co-authors

Recent publications by Dr. Vance

See all 7 publications and co-authors

See who Dr. Vance researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Vance works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Estil August Vance III has worked on 1 clinical trial

Dmand AI links Dr. Vance to 1 clinical trial. Conditions studied include Lymphoma, Large-Cell, Anaplastic and Lymphoma, T-Cell.

Conditions in Dr. Vance's trials

  • Lymphoma, Large-Cell, Anaplastic
  • Lymphoma, T-Cell

Investigators on the most trials with Dr. Vance

Recent clinical trials with Dr. Vance

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Estil August Vance III received $5,327 in industry payments from 2016 to 2025

CMS Open Payments shows 49 general payments to Dr. Vance from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 75% of the total. Celgene Corporation paid the most, $4,236.

General payments to Dr. Vance by program year, 2016 to 2025

General payments to Dr. Vance by kind, 2016 to 2025

$5.3Kin total
  • Speaker and faculty fees$4,00075%
  • Food and beverage$1,23823%
  • Education$892%

Companies that paid Dr. Vance the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Vance

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Estil August Vance III has 1 award and honors on record

Dmand AI lists 1 award for Dr. Vance.

Awards and honors for Dr. Vance

  1. Undated
    • Super Doc

Source: Dmand AI Professional Profile Data

Dr. Estil August Vance III graduated from The Johns Hopkins University School of Medicine

Dr. Vance graduated from The Johns Hopkins University School of Medicine in 1990. Dr. Vance is a member of ACP.

  1. Medical schoolThe Johns Hopkins University School of Medicine
  2. Board certified in medical oncologyNational Board of Physicians and Surgeons

Source: Dmand AI Professional Profile Data

Dr. Estil August Vance III accepts plans from 24 insurance carriers

Dr. Vance is in network with 24 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.

Plan types Dr. Vance accepts, by number of carriers

  1. PPO15
  2. HMO14
  3. Medicare12
  4. POS7
  5. EPO5

Source: Dmand AI Insurance Network Data

Sources for Dr. Estil August Vance III's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Estil August Vance III

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Estil August Vance III's NPI number?

Dr. Estil August Vance III's NPI number is 1477596344. It was assigned on June 14, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Estil August Vance III?

Dr. Estil August Vance III is a hematologist and oncologist in Dallas, Texas. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Estil August Vance III practice?

Dr. Vance practices at 7777 Forest Lane, Dallas, TX 75230. Dr. Vance's primary practice is Medical City Dallas Hospital in Dallas, Texas, part of HCA Healthcare. Dmand AI also links Dr. Vance to 1 hospital.

What is Dr. Estil August Vance III's office phone number?

The practice phone on file for Dr. Vance is (972) 566-6222.

What is Dr. Estil August Vance III's medical license number?

Dr. Vance's Texas license number on file is K6385.

Which hospitals is Dr. Estil August Vance III affiliated with?

Dr. Vance practices at Medical City Dallas Hospital in Dallas, Texas. Dmand AI links Dr. Vance to 1 more hospital.

What medical group is Dr. Estil August Vance III part of?

Dr. Vance is linked to Texas Oncology.

Does Dr. Estil August Vance III accept Medicare?

Yes. CMS data shows Dr. Vance billed Medicare for 5,439 services in 2024, and Dr. Vance accepts Medicare assignment.

Does Dr. Estil August Vance III offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Vance as offering telehealth services.

What is Dr. Estil August Vance III's MIPS score?

Dr. Vance's MIPS final score for performance year 2024 is 85 out of 100, reported through an alternative payment model (APM).

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Estil August Vance III see?

CMS counts 349 Medicare patients who saw Dr. Vance in 2024, with an average age of 71.

Is Dr. Estil August Vance III board certified?

Yes. Dr. Vance is board certified in medical oncology by the National Board of Physicians and Surgeons.

What services does Dr. Estil August Vance III bill to Medicare?

In 2024, Dr. Vance's most billed Medicare services were hospital inpatient care (99232), hospital inpatient care (99231) and lab and pathology test (80053).

Where did Dr. Estil August Vance III go to medical school?

Dr. Vance graduated from The Johns Hopkins University School of Medicine in 1990.

What drugs does Dr. Estil August Vance III prescribe most?

In 2024 Medicare Part D data, Dr. Vance's most prescribed drugs by claims were Acyclovir, Gabapentin and Valacyclovir.

Has Dr. Estil August Vance III received payments from drug or device companies?

CMS Open Payments shows $5,327 in general payments to Dr. Vance from 15 companies from 2016 to 2025. The largest total came from Celgene Corporation.

How long has Dr. Estil August Vance III been practicing?

Dr. Vance graduated from medical school in 1990, 36 years ago.

Does Dr. Estil August Vance III do research?

Dmand AI links 7 publications to Dr. Vance. Dr. Vance has worked on 1 clinical trial.

Who does Dr. Estil August Vance III publish with?

Dr. Vance's most frequent co-authors are Vikas Bhushan, MD (2 shared papers), Tara Brooke Kelley Gregory, MD (2 shared papers) and Charles F. Lemaistre, MD (2 shared papers).

What insurance does Dr. Estil August Vance III accept?

Dr. Vance is in network with 24 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in Texas by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)